News
Media
Between the Lines
Expert Interviews
K-Cast
Medical World News
Podcasts
Population Health Perspectives
Shorts
Conferences
Partners
More
Publications
All Publications
MHE Publication
Formulary Watch Supplements
Formulary Watch Spotlights
Supplements And Featured Publications
Events
Webinars
CME/CE
Resources
PBMI Innovators
Emerging Leaders
Interactive Tools
Sponsored Content
PBM Directory
Subscribe
My Account
News
Media
Conferences
Partners
Publications
Events
CME/CE
Resources
PBM Directory
Subscribe
Acute Pain
Asthma
Atrial Fibrillation
Autoimmune Diseases
Biologics
Biosimilars
Blood Cancer
Breast Cancer
COVID-19
Cardiovascular Diseases
Depression
Dermatology
Diabetes
Digital Health
Drug Coverage
Duchenne Muscular Dystrophy
Eyecare
FDA
Friedreich Ataxia
Gene Therapy
Graft Versus Host Disease
HIV
Health Systems
Heart Failure
Hemophilia
Hypertrophic Cardiomyopathy (HCM)
Infectious Disease
Leukemia and Lymphoma
Liver Disease
Lung Cancer
Mental Health
Metabolic Dysfunction-Associated Steatohepatitis
Multiple Sclerosis
NSCLC
Neonatal Care
Nephrology
Obstetrics-Gynecology & Women's Health
Oncology
Oncology Biomarkers
Opioids
PTSD
Pediatrics
Plaque Psoriasis
Population Health
Post-Acute Care
Prescription Digital Therapeutics
Pulmonary Arterial Hypertension
RSV
Reproductive Health
Respiratory Conditions
Safety & Recalls
Schizophrenia
Shingles
Skin Cancer
Sleep Disorders
Solid Tumors
Spinal Muscular Atrophy
Substance Use Disorder
The Improving Patient Access Podcast
Type I Diabetes
Type II Inflammation
Ulcerative Colitis
Uro-Oncology
Urothelial Carcinoma
Vaccines
Women's Health
Year in Review- Dermatology
Choose Topic
Spotlight -
Our June 2026 print issue
|
Free Webinar: The Economics of Cell and Gene Therapy
|
2026 ASCO Annual Meeting
|
2026 State of Pharmacy survey results available now
Advertisement
New Insights Into ADHD
New Insights Into ADHD
June 3rd 2026
An in-depth look into current treatments of ADHD.
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
CagriSema reduces HbA1c, weight across T2D spectrum in REIMAGINE trials | ADA 2026
2
Lee Kaplan, M.D., discusses the metabolic case for survodutide | ADA 2026
3
Nearly half of older adults with metastatic lung cancer never receive systemic therapy, study finds
4
Machine learning model predicts T2D risk up to 10 years before onset
5
Circulating tumor DNA shows prognostic power in early breast cancer, but clinical utility remains unproven